A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

Trial Profile

A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 May 2016

At a glance

  • Drugs Indacaterol (Primary) ; Budesonide/formoterol; Salmeterol/fluticasone propionate; Theophylline; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Novartis Pharmaceuticals
  • Most Recent Events

    • 06 May 2016 Status changed from recruiting to completed.
    • 02 Jan 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2015 to 1 May 2015.
    • 02 Jan 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Aug 2015 to 1 May 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top